Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency

Clinical Endocrinology

Volumn 74, Issue 2, 2011, Pages 166-173

  Reisch, Nicole ^a,b   Hahner, Stefanie ^c   Bleicken, Benjamin ^d   Flade, Linda ^b   Gil, Francesco Pedrosa ^b   Loeffler, Melanie ^c   Ventz, Manfred ^d   Hinz, Andreas ^e   Beuschlein, Felix ^b   Allolio, Bruno ^c   Reincke, Martin ^b   Quinkler, Marcus ^d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; PREDNISOLONE; PREDNISONE;

ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FUNCTIONAL STATUS; GIESSEN SUBJECTIVE COMPLAINTS LIST; HORMONE SUBSTITUTION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIMARY ADRENAL INSUFFICIENCY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF EVALUATION; SHORT FORM 36; SOCIAL STATUS; STEROID 21 MONOOXYGENASE DEFICIENCY; TERTIARY HEALTH CARE;

ADDISON DISEASE; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 78651338052     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03920.x     Document Type: Article

References (29)

1. Merke, D.P., &, Bornstein, S.R., (2005) Congenital adrenal hyperplasia. Lancet 365, 2125-2136.
2. Bachelot, A., Chakthoura, Z., Rouxel, A., et al. (2008) Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults. Hormone Research 69, 203-211.
3. Arlt, W., &, Krone, N., (2007) Adult consequences of congenital adrenal hyperplasia. Hormone Research 68 (Suppl 5), 158-164.
4. Kuhnle, U., Bullinger, M., &, Schwarz, H.P., (1995) The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life. European Journal of Pediatrics 154, 708-716.
5. Rivkees, S.A., &, Crawford, C.D., (2000) Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 106, 767-773.
6. Jääskeläinen, J., &, Voutilainen, R., (2000) Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatrica 89, 183-187.
7. Johannsen, T.H., Ripa, C.P., Mortensen, E.L., et al. (2006) Quality of life in 70 women with disorders of sex development. European Journal of Endocrinology 155, 877-885.
8. Hahner, S., Loeffler, M., Fassnacht, M., et al. (2007) Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. Journal of Clinical Endocrinology and Metabolism 92, 3912-3922.
9. Lovas, K., Loge, J.H., &, Husebye, E.S., (2002) Subjective health status in Norwegian patients with Addison's disease. Clinical Endocrinology 56, 581-588.
10. Thomsen, A.F., Kvist, T.K., Andersen, P.K., et al. (2006) The risk of affective disorders in patients with adrenocortical insufficiency. Psychoneuroendocrinology 31, 614-622.
11. Bleicken, B., Hahner, S., Loeffler, M., et al. (2008) Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. European Journal of Endocrinology 159, 811-817.
12. Garratt, A., Schmidt, L., Mackintosh, A., et al. (2002) Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 324, 1417.
13. Nemeth, G., (2006) Health related quality of life outcome instruments. European Spine Journal 15 (Suppl 1), S44-S51.
14. Brahler, E., Schumacher, J., &, Brahler, C., (2000) [First all-Germany standardization of the brief form of the Giessen Complaints Questionnaire GBB-24]. Psychotherapie, Psychosomatik, Medizinische Psychologie 50, 14-21.
15. Zigmond, A.S., &, Snaith, R.P., (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67, 361-370.
16. Hinz, A., &, Schwarz, R., (2001) [Anxiety and depression in the general population: normal values in the Hospital Anxiety and Depression Scale]. Psychotherapie, Psychosomatik, Medizinische Psychologie 51, 193-200.
17. Nordenskjold, A., Holmdahl, G., Frisen, L., et al. (2008) Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 93, 380-386.
18. Berenbaum, S.A., Korman Bryk, K., Duck, S.C., et al. (2004) Psychological adjustment in children and adults with congenital adrenal hyperplasia. Journal of Pediatrics 144, 741-746.
19. Frisen, L., Nordenstrom, A., Falhammar, H., et al. (2009) Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. Journal of Clinical Endocrinology and Metabolism 94, 3432-3439.
20. Bleicken, B., Hahner, S., Loeffler, M., et al. (2010) Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clinical Endocrinology 72, 297-304.
21. Reisch, N., &, Arlt, W., (2009) Fine tuning for quality of life: 21st century approach to treatment of Addison's disease. Endocrinology and Metabolism Clinics of North America 38, 407-418, ix-x.
22. Arlt, W., Callies, F., van Vlijmen, J.C., et al. (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. New England Journal of Medicine 341, 1013-1020.
23. Johannsson, G., Burman, P., Wiren, L., et al. (2002) Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 87, 2046-2052.
24. Hunt, P.J., Gurnell, E.M., Huppert, F.A., et al. (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. Journal of Clinical Endocrinology and Metabolism 85, 4650-4656.
25. Brooke, A.M., Kalingag, L.A., Miraki-Moud, F., et al. (2006) Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement. Journal of Clinical Endocrinology and Metabolism 91, 3773-3779.
26. Gurnell, E.M., Hunt, P.J., Curran, S.E., et al. (2008) Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. Journal of Clinical Endocrinology and Metabolism 93, 400-409.
27. Reisch, N., Flade, L., Scherr, M., et al. (2009) High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 94, 1665-1670.
28. Hofbauer, L.C., Allolio, B., &, Arlt, W., (2002) Dehydroepiandrosterone supplementation in elderly men: the role of estrogens versus androgens on the male skeleton. Journal of Clinical Endocrinology and Metabolism 87, 4009; author reply 4009.
29. Arlt, W., Callies, F., Koehler, I., et al. (2001) Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. Journal of Clinical Endocrinology and Metabolism 86, 4686-4692.